Exercise may shield the brain in MS patients, new trial hopes to prove
NCT ID NCT07521995
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will test whether a 12-week progressive resistance training program can improve brain health and daily function in people with relapsing-remitting multiple sclerosis. Thirty participants will be randomly assigned to either an exercise group or a control group. Researchers will measure changes in a blood marker called GFAP, brain volume via MRI, and functional outcomes like walking and fatigue.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- progressive resistance training (exercise program)
- What this could lead to
- If successful, this could show that a structured exercise program helps protect the brain and improve daily function in people with multiple sclerosis.
- What could go wrong
- This is a small, early-stage trial with only 30 people, so results may not apply to everyone. It measures changes in blood markers and brain scans, not long-term disability.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXERCISE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fırat University
Elâzığ, 23100, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we decode the different types of pain in multiple sclerosis?
- Can a blood pressure pill slow MS disability?
- Water workouts could be the key to back pain relief
- Hidden MS progression: can brain scans and blood tests predict it?
- Can Brain-Training apps fix sleep in MS?
- Can an Iron-Based dye reveal hidden inflammation in progressive MS?